Adenosine: A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.Receptor, Adenosine A2A: A subclass of adenosine A2 receptors found in LEUKOCYTES, the SPLEEN, the THYMUS and a variety of other tissues. It is generally considered to be a receptor for ADENOSINE that couples to the GS, STIMULATORY G-PROTEIN.Receptor, Adenosine A1: A subtype of ADENOSINE RECEPTOR that is found expressed in a variety of tissues including the BRAIN and DORSAL HORN NEURONS. The receptor is generally considered to be coupled to the GI, INHIBITORY G-PROTEIN which causes down regulation of CYCLIC AMP.Adenosine Deaminase: An enzyme that catalyzes the hydrolysis of ADENOSINE to INOSINE with the elimination of AMMONIA.Receptor, Adenosine A3: A subtype of ADENOSINE RECEPTOR that is found expressed in a variety of locations including the BRAIN and endocrine tissues. The receptor is generally considered to be coupled to the GI, INHIBITORY G-PROTEIN which causes down regulation of CYCLIC AMP.Receptor, Adenosine A2B: A subclass of adenosine A2 receptors found in the CECUM, the COLON, the BLADDER, and a variety of other tissues. It is generally considered to be a low affinity receptor for ADENOSINE that couples to the GS, STIMULATORY G-PROTEIN.Adenosine Kinase: An enzyme that catalyzes the formation of ADP plus AMP from adenosine plus ATP. It can serve as a salvage mechanism for returning adenosine to nucleic acids. EC 184.108.40.206.Receptors, Adenosine A2: A subclass of ADENOSINE RECEPTORS that are generally considered to be coupled to the GS, STIMULATORY G-PROTEIN which causes up regulation of CYCLIC AMP.Adenosine A2 Receptor Agonists: Compounds that selectively bind to and activate ADENOSINE A2 RECEPTORS.Adenosine A2 Receptor Antagonists: Compounds that selectively bind to and block the activation of ADENOSINE A2 RECEPTORS.Receptors, Purinergic P1: A class of cell surface receptors that prefer ADENOSINE to other endogenous PURINES. Purinergic P1 receptors are widespread in the body including the cardiovascular, respiratory, immune, and nervous systems. There are at least two pharmacologically distinguishable types (A1 and A2, or Ri and Ra).Adenosine A1 Receptor Antagonists: Compounds that bind to and block the stimulation of ADENOSINE A1 RECEPTORS.Adenosine A1 Receptor Agonists: Compounds that bind to and stimulate ADENOSINE A1 RECEPTORS.Purinergic P1 Receptor Antagonists: Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS.Xanthines: Purine bases found in body tissues and fluids and in some plants.Purinergic P1 Receptor Agonists: Compounds that bind to and stimulate PURINERGIC P1 RECEPTORS.Adenosine Monophosphate: Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2'-, 3'-, or 5'-position.Adenosine-5'-(N-ethylcarboxamide): A stable adenosine A1 and A2 receptor agonist. Experimentally, it inhibits cAMP and cGMP phosphodiesterase activity.Theophylline: A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP.Adenosine A3 Receptor Antagonists: Compounds that selectively bind to and block the activation of ADENOSINE A3 RECEPTORS.Receptors, Purinergic: Cell surface proteins that bind PURINES with high affinity and trigger intracellular changes which influence the behavior of cells. The best characterized classes of purinergic receptors in mammals are the P1 receptors, which prefer ADENOSINE, and the P2 receptors, which prefer ATP or ADP.Adenosine A3 Receptor Agonists: Drugs that selectively bind to and activate ADENOSINE A3 RECEPTORS.2-Chloroadenosine: 2-Chloroadenosine. A metabolically stable analog of adenosine which acts as an adenosine receptor agonist. The compound has a potent effect on the peripheral and central nervous system.Phenethylamines: A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed)Phenylisopropyladenosine: N-Isopropyl-N-phenyl-adenosine. Antilipemic agent. Synonym: TH 162.Inosine: A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)5'-Nucleotidase: A glycoprotein enzyme present in various organs and in many cells. The enzyme catalyzes the hydrolysis of a 5'-ribonucleotide to a ribonucleoside and orthophosphate in the presence of water. It is cation-dependent and exists in a membrane-bound and soluble form. EC 220.127.116.11.Cyclic AMP: An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH.Adenosine Triphosphatases: A group of enzymes which catalyze the hydrolysis of ATP. The hydrolysis reaction is usually coupled with another function such as transporting Ca(2+) across a membrane. These enzymes may be dependent on Ca(2+), Mg(2+), anions, H+, or DNA.Tubercidin: An antibiotic purine ribonucleoside that readily substitutes for adenosine in the biological system, but its incorporation into DNA and RNA has an inhibitory effect on the metabolism of these nucleic acids.Adenine NucleotidesNucleoside Deaminases: Catalyze the hydrolysis of nucleosides with the elimination of ammonia.Coformycin: A ribonucleoside antibiotic synergist and adenosine deaminase inhibitor isolated from Nocardia interforma and Streptomyces kaniharaensis. It is proposed as an antineoplastic synergist and immunosuppressant.Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)Theobromine: 3,7-Dimethylxanthine. The principle alkaloid in Theobroma cacao (the cacao bean) and other plants. A xanthine alkaloid that is used as a bronchodilator and as a vasodilator. It has a weaker diuretic activity than THEOPHYLLINE and is also a less powerful stimulant of smooth muscle. It has practically no stimulant effect on the central nervous system. It was formerly used as a diuretic and in the treatment of angina pectoris and hypertension. (From Martindale, The Extra Pharmacopoeia, 30th ed, pp1318-9)Pentostatin: A potent inhibitor of ADENOSINE DEAMINASE. The drug induces APOPTOSIS of LYMPHOCYTES, and is used in the treatment of many lymphoproliferative malignancies, particularly HAIRY CELL LEUKEMIA. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity.Adenosine Phosphosulfate: 5'-Adenylic acid, monoanhydride with sulfuric acid. The initial compound formed by the action of ATP sulfurylase on sulfate ions after sulfate uptake. Synonyms: adenosine sulfatophosphate; APS.Purines: A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.Thioinosine: Sulfhydryl analog of INOSINE that inhibits nucleoside transport across erythrocyte plasma membranes, and has immunosuppressive properties. It has been used similarly to MERCAPTOPURINE in the treatment of leukemia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p503)Triazines: Heterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES.Adenine: A purine base and a fundamental unit of ADENINE NUCLEOTIDES.Deoxyadenosines: Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule.Purinergic Antagonists: Drugs that bind to and block the activation of PURINERGIC RECEPTORS.Kinetics: The rate dynamics in chemical or physical systems.Aminophylline: A drug combination that contains THEOPHYLLINE and ethylenediamine. It is more soluble in water than theophylline but has similar pharmacologic actions. It's most common use is in bronchial asthma, but it has been investigated for several other applications.Vasodilator Agents: Drugs used to cause dilation of the blood vessels.Dose-Response Relationship, Drug: The relationship between the dose of an administered drug and the response of the organism to the drug.Nucleoside Transport Proteins: Proteins involved in the transport of NUCLEOSIDES across cellular membranes.Hypoxanthine: A purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway.Nucleotidases: A class of enzymes that catalyze the conversion of a nucleotide and water to a nucleoside and orthophosphate. EC 3.1.3.-.Hypoxanthines: Purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.TriazolesNucleosides: Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed)Apyrase: A calcium-activated enzyme that catalyzes the hydrolysis of ATP to yield AMP and orthophosphate. It can also act on ADP and other nucleoside triphosphates and diphosphates. EC 18.104.22.168.Coronary Circulation: The circulation of blood through the CORONARY VESSELS of the HEART.Adenylate Cyclase: An enzyme of the lyase class that catalyzes the formation of CYCLIC AMP and pyrophosphate from ATP. EC 22.214.171.124.Bucladesine: A cyclic nucleotide derivative that mimics the action of endogenous CYCLIC AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. (From Merck Index, 11th ed)Cells, Cultured: Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.Guinea Pigs: A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research.Ribonucleosides: Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)Rats, Sprague-Dawley: A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.Adenosylhomocysteinase: An enzyme which catalyzes the catabolism of S-ADENOSYLHOMOCYSTEINE to ADENOSINE and HOMOCYSTEINE. It may play a role in regulating the concentration of intracellular adenosylhomocysteine.Receptors, Purinergic P2: A class of cell surface receptors for PURINES that prefer ATP or ADP over ADENOSINE. P2 purinergic receptors are widespread in the periphery and in the central and peripheral nervous system.Calcium: A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.Myocardium: The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow.Rats, Wistar: A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain.Nucleotides: The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed)Dogs: The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)8-Bromo Cyclic Adenosine Monophosphate: A long-acting derivative of cyclic AMP. It is an activator of cyclic AMP-dependent protein kinase, but resistant to degradation by cyclic AMP phosphodiesterase.Colforsin: Potent activator of the adenylate cyclase system and the biosynthesis of cyclic AMP. From the plant COLEUS FORSKOHLII. Has antihypertensive, positive inotropic, platelet aggregation inhibitory, and smooth muscle relaxant activities; also lowers intraocular pressure and promotes release of hormones from the pituitary gland.Magnesium: A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.Caffeine: A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling.Extracellular Space: Interstitial space between cells, occupied by INTERSTITIAL FLUID as well as amorphous and fibrous substances. For organisms with a CELL WALL, the extracellular space includes everything outside of the CELL MEMBRANE including the PERIPLASM and the cell wall.Hyperemia: The presence of an increased amount of blood in a body part or an organ leading to congestion or engorgement of blood vessels. Hyperemia can be due to increase of blood flow into the area (active or arterial), or due to obstruction of outflow of blood from the area (passive or venous).1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASESVasodilation: The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE.Rabbits: The species Oryctolagus cuniculus, in the family Leporidae, order LAGOMORPHA. Rabbits are born in burrows, furless, and with eyes and ears closed. In contrast with HARES, rabbits have 22 chromosome pairs.NorbornanesTime Factors: Elements of limited time intervals, contributing to particular results or situations.Perfusion: Treatment process involving the injection of fluid into an organ or tissue.Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.S-Adenosylhomocysteine: 5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions.Purine Nucleosides: Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES.Radioligand Assay: Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders).Dinucleoside Phosphates: A group of compounds which consist of a nucleotide molecule to which an additional nucleoside is attached through the phosphate molecule(s). The nucleotide can contain any number of phosphates.Phosphodiesterase Inhibitors: Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases.RNA Editing: A process that changes the nucleotide sequence of mRNA from that of the DNA template encoding it. Some major classes of RNA editing are as follows: 1, the conversion of cytosine to uracil in mRNA; 2, the addition of variable number of guanines at pre-determined sites; and 3, the addition and deletion of uracils, templated by guide-RNAs (RNA, GUIDE).Equilibrative Nucleoside Transporter 1: A subtype of equilibrative nucleoside transporter proteins that is sensitive to inhibition by 4-nitrobenzylthioinosine.4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone: Inhibitor of phosphodiesterases.Adenosine Diphosphate Sugars: Esters formed between the aldehydic carbon of sugars and the terminal phosphate of adenosine diphosphate.Thionucleotides: Nucleotides in which the base moiety is substituted with one or more sulfur atoms.Purinergic P2 Receptor Antagonists: Compounds that bind to and block the stimulation of PURINERGIC P2 RECEPTORS.Guanosine: A purine nucleoside that has guanine linked by its N9 nitrogen to the C1 carbon of ribose. It is a component of ribonucleic acid and its nucleotides play important roles in metabolism. (From Dorland, 28th ed)Enzyme Inhibitors: Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.Rats, Inbred Strains: Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding.Heart: The hollow, muscular organ that maintains the circulation of the blood.Signal Transduction: The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.Equilibrative-Nucleoside Transporter 2: A subtype of equilibrative nucleoside transporter proteins that is insensitive to inhibition by 4-nitrobenzylthioinosine.Platelet Aggregation: The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS.Phosphotransferases: A rather large group of enzymes comprising not only those transferring phosphate but also diphosphate, nucleotidyl residues, and others. These have also been subdivided according to the acceptor group. (From Enzyme Nomenclature, 1992) EC 2.7.Enzyme Activation: Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme.Glyburide: An antidiabetic sulfonylurea derivative with actions similar to those of chlorpropamide.Cell Membrane: The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells.Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.Cell Line: Established cell cultures that have the potential to propagate indefinitely.Anoxia: Relatively complete absence of oxygen in one or more tissues.3',5'-Cyclic-AMP Phosphodiesterases: Enzymes that catalyze the hydrolysis of CYCLIC AMP to form adenosine 5'-phosphate. The enzymes are widely distributed in animal tissue and control the level of intracellular cyclic AMP. Many specific enzymes classified under this heading demonstrate additional spcificity for 3',5'-cyclic IMP and CYCLIC GMP.Formycins: Pyrazolopyrimidine ribonucleosides isolated from Nocardia interforma. They are antineoplastic antibiotics with cytostatic properties.Cyclic AMP-Dependent Protein Kinases: A group of enzymes that are dependent on CYCLIC AMP and catalyze the phosphorylation of SERINE or THREONINE residues on proteins. Included under this category are two cyclic-AMP-dependent protein kinase subtypes, each of which is defined by its subunit composition.Stimulation, Chemical: The increase in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical.Purine-Nucleoside Phosphorylase: An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 126.96.36.199.Coronary Vessels: The veins and arteries of the HEART.AMP Deaminase: An enzyme that catalyzes the deamination of AMP to IMP. EC 188.8.131.52.Potassium Channels: Cell membrane glycoproteins that are selectively permeable to potassium ions. At least eight major groups of K channels exist and they are made up of dozens of different subunits.Cattle: Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.Purinergic P2 Receptor Agonists: Compounds that bind to and stimulate PURINERGIC P2 RECEPTORS.Ischemic Preconditioning, Myocardial: Exposure of myocardial tissue to brief, repeated periods of vascular occlusion in order to render the myocardium resistant to the deleterious effects of ISCHEMIA or REPERFUSION. The period of pre-exposure and the number of times the tissue is exposed to ischemia and reperfusion vary, the average being 3 to 5 minutes.Potassium: An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.Ribose: A pentose active in biological systems usually in its D-form.Binding Sites: The parts of a macromolecule that directly participate in its specific combination with another molecule.Dilazep: Coronary vasodilator with some antiarrhythmic activity.Hydrogen-Ion Concentration: The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH = log 1/2[1/(H+)], where (H+) is the hydrogen ion concentration in gram equivalents per liter of solution. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)Uridine Triphosphate: Uridine 5'-(tetrahydrogen triphosphate). A uracil nucleotide containing three phosphate groups esterified to the sugar moiety.Affinity Labels: Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids.Mice, Inbred C57BLDideoxyadenosine: A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is an inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal side effect is nephrotoxicity. In vivo, dideoxyadenosine is rapidly metabolized to DIDANOSINE (ddI) by enzymatic deamination; ddI is then converted to dideoxyinosine monophosphate and ultimately to dideoxyadenosine triphosphate, the putative active metabolite.Isopentenyladenosine: N(6)-[delta(3)-isopentenyl]adenosine. Isopentenyl derivative of adenosine which is a member of the cytokinin family of plant growth regulators.Depression, Chemical: The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical.
List of MeSH codes (D13)
... adenosine monophosphate MeSH D13.695.667.138.180.080 --- adenosine phosphosulfate MeSH D13.695.667.138.236 --- adenosine ... n-ethylcarboxamide) MeSH D13.570.583.138.240 --- s-adenosylhomocysteine MeSH D13.570.583.138.264 --- s-adenosylmethionine MeSH ... adenosine monophosphate MeSH D13.695.827.068.180.080 --- adenosine phosphosulfate MeSH D13.695.827.068.236 --- adenosine ... adenosine diphosphate sugars MeSH D13.695.667.138.124.070.075 --- adenosine diphosphate glucose MeSH D13.695.667.138.124.070. ...
Adenosine A2B receptor
N-ethylcarboxamide induces IL-6 expression via MAPKs and NF-kappaB activation through Akt, Ca(2+)/PKC, cAMP signaling pathways ... The adenosine A2B receptor, also known as ADORA2B, is a G-protein coupled adenosine receptor, and also denotes the human ... 2001). "Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes ... Strohmeier GR, Reppert SM, Lencer WI, Madara JL (1995). "The A2b adenosine receptor mediates cAMP responses to adenosine ...
Pharmacological Stress Myocardial Perfusion Imaging With the Potent and Selective A2A Adenosine Receptor Agonists ATL193 and...
... hydroxyl group of the ribose on the ATL compounds is protected from phosphorylation by the addition of N-ethylcarboxamide. ... Maximal CF response after bolus of ATL-146e was greater and more sustained than with adenosine. Note that adenosine flow ... No pharmacodynamic half-life data were reported for the adenosine boluses owing to the fact that the adenosine response was ... because comparisons were made between the adenosine A2A receptor agonists and adenosine in the same anesthetized animal model. ...http://circ.ahajournals.org/content/104/10/1181
Adenosine-5'-(N-ethylcarboxamide) - NECA Summary Report | CureHunter
N-ethylcarboxamide): A stable adenosine A1 and A2 receptor agonist. Experimentally, it inhibits cAMP and cGMP phosphodiesterase ... N-ethylcarboxamide) A stable adenosine A1 and A2 receptor agonist. Experimentally, it inhibits cAMP and cGMP phosphodiesterase ... ethylcarboxamide-adenosine (NECA), N6-phenylisopropyladenosine (PIA) and N6-cyclohexyladenosine (CHA) induced dose dependent ... N-ethylcarboxamide) (NECA). Subscribe to New Research on Adenosine-5'-( ...http://www.curehunter.com/public/keywordSummaryD019830-Adenosine-5---N-ethylcarboxamide--NECA.do
Jon Mabley - Fingerprint - The University of Brighton
N-ethylcarboxamide) Oxidants Adenosine Diphosphate Ribose Interleukin-12 Cell Death ...https://research.brighton.ac.uk/en/persons/jon-mabley/fingerprints/
PlumX - Adenosine A1 receptors mediate mobilization of calcium in human bronchial smooth muscle cells.
N-ethylcarboxamide); Biological Transport, Active; Bronchi; *Calcium Signaling; Cells, Cultured; Cyclic AMP; GTP-Binding ... selective agonists at adenosine A(2A) receptors and adenosine A(3) receptors, respectively. Calcium responses to NECA and CPA ... N-ethylcarboxamido-adenosine (100 nM) or N(6)-(3-iodobenzyl)-adenosine-5'-N-methyluronamide (100 nM), ... Adenosine A1 receptors mediate mobilization of calcium in human bronchial smooth muscle cells.. Citation data: American journal ...https://plu.mx/plum/a/--9003HdxfXUceiJoLLHo6L2S2shEf66ymSBmCguGRY/
CLONAZEPAM | SelfDecode | Genome Analysis
Clonazepam affects the reaction [Adenosine-5'-(N-ethylcarboxamide) results in increased expression of CXCL8 protein]. R ... Gamma-aminobutyric acid receptor subunit alpha-5. Gamma-aminobutyric acid receptor subunit beta-1. Gamma-aminobutyric acid ...https://www.selfdecode.com/chemical/clonazepam/
NAVER Academic > Search...
Adenosine, analogs & derivatives, chemistry, metabolism, Adenosine-5'-(N-ethylcarboxamide), Animals, Cell Membrane, Corpus ... Adenosine Triphosphatases, antagonists & inhibitors, Adenosine Triphosphate, pharmacology, Anions, Atractyloside, analogs & ... Role of cysteine residues of rat A2a adenosine receptors in agonist binding.. 1997 M R Mazzoni et al. Biochimica et biophysica ... Adenosine Monophosphate, pharmacology, Animals, Biological Transport, Caffeine, Calcium, metabolism, Calcium Channels, ...https://academic.naver.com/search.naver?field=3&query=Biochimica+et+Biophysica+Acta+1324%EA%B6%8C+1%ED%98%B8
DI-fusion The role of spinal and brainstem adenosine receptors in the...
N-ethylcarboxamide). Animals. Brain Stem -- drug effects. Brain Stem -- metabolism. ... The role of spinal and brainstem adenosine receptors in the modulation of the volume-evoked micturition reflex in the ... The role of spinal and brainstem adenosine receptors in the modulation of the volume-evoked micturition reflex in the ... Assessment of the role of A1/A2 adenosine receptors mediating the purine antinociception, motor and autonomic function in the ...https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/58752/Details
WikiGenes - Adora2a - adenosine A2a receptor
N-ethyl-carboxamide-adenos ine (CGS21680), a selective adenosine A2A receptor agonist, enhanced taurine release, while ... Purinergic P2 receptors trigger adenosine release leading to adenosine A2A receptor activation and facilitation of long-term ... Purinergic P2 receptors trigger adenosine release leading to adenosine A2A receptor activation and facilitation of long-term ... Effects of an adenosine A2A receptor blockade in the nucleus accumbens on locomotion, feeding, and prepulse inhibition in rats. ...https://www.wikigenes.org/e/gene/e/25369.html
List of MeSH codes (D13) - Wikipedia
... adenosine monophosphate MeSH D13.695.667.138.180.080 --- adenosine phosphosulfate MeSH D13.695.667.138.236 --- adenosine ... n-ethylcarboxamide) MeSH D13.570.583.138.240 --- s-adenosylhomocysteine MeSH D13.570.583.138.264 --- s-adenosylmethionine MeSH ... adenosine monophosphate MeSH D13.695.827.068.180.080 --- adenosine phosphosulfate MeSH D13.695.827.068.236 --- adenosine ... adenosine diphosphate sugars MeSH D13.695.667.138.124.070.075 --- adenosine diphosphate glucose MeSH D13.695.667.138.124.070. ...https://en.wikipedia.org/wiki/List_of_MeSH_codes_(D13)
Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated...
... we investigated the effect of adenosine on myeloid cells and explored a possible contribution of myeloid cells to adenosine ... Little, however, is known about the effect of adenosine on myeloid cells. Considering that tumor associated macrophages (TAM) ... tissues show abundant expression of the ectonucleotidases CD39 and CD73 which generate immunomodulatory adenosine, thereby ... N-ethylcarboxamide (NECA, Tocris) was employed at 100 nM. To control for effects of adenosine on chemokinesis, a control ...https://jitc.biomedcentral.com.preview-live.oscarjournals.springer.com/articles/10.1186/s40425-016-0154-9
Spinal Adenosine Receptor Activation Reduces Hypersensitivity after Surgery by a Different Mechanism Than after Nerve Injury |...
... ethylcarboxamide adenosine. Brain Res 1990; 519:287-93 ... Antinociception by adenosine analogs and an adenosine kinase ... 19 Adenosine receptors are present on intrinsic interneurons in the dorsal horn. 2 It is conceivable that these adenosine ... Poon A, Sawynok J: Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal ... in which adenosine is inactive. The mechanisms of norepinephrine release by activation of spinal adenosine A1 receptors after ...http://anesthesiology.pubs.asahq.org/article.aspx?articleid=1943070
"Adenylyl Cyclase Type 6 Overexpression Selectively Enhances ß-Adrenerg" by Xiaoqiu Liu, Muthusamy Thangavel et al.
... adenosine (adenosine-5′-N-ethylcarboxamide, NECA), and prostacyclin (beraprost) receptors. Overexpression of AC6 increased cAMP ... cyclic adenosine monophosphate (cAMP) levels. cAMP signal generation and response is known to be compartmentalized in many cell ... Fibroblasts are activated by factors such as transforming growth factor β and inhibited by agents that elevate 3′,5′- ... N-ethylcarboxamide, NECA), and prostacyclin (beraprost) receptors. Overexpression of AC6 increased cAMP production stimulated ...https://digitalcommons.chapman.edu/pharmacy_articles/382/
US Patent for Tricyclic fused pyrimidine derivatives, their production and use Patent (Patent # 5,032,594 issued July 16, 1991...
... and A is an optionally substituted divalent hydrocarbon chain having 2 to 4 carbon atoms and salts thereof are strong adenosine ... adenosine triphosphate (ATP) of a high-energy compound is decreased to increase the adenosine concentration, and the adenosine ... ethylcarboxamide (.sup.3 H-NECA; about 0.1 .mu.Ci) as ligand, the experiment was conducted in the presence of 50 nM of ... Use of an adenosine antagonist inhibiting the interaction between adenosine and its receptors is considered useful for the ...https://patents.justia.com/patent/5032594
Adenosine A2B receptor - Wikipedia
N-ethylcarboxamide induces IL-6 expression via MAPKs and NF-kappaB activation through Akt, Ca(2+)/PKC, cAMP signaling pathways ... The adenosine A2B receptor, also known as ADORA2B, is a G-protein coupled adenosine receptor, and also denotes the human ... 2001). "Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes ... Strohmeier GR, Reppert SM, Lencer WI, Madara JL (1995). "The A2b adenosine receptor mediates cAMP responses to adenosine ...https://en.wikipedia.org/wiki/Adenosine_A2B_receptor
Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy -ORCA
N-ethylcarboxamide, NECA) and the A2AR agonist (CGS21680) stimulated cell proliferation by up to 20-40% which was attenuated by ... adenosine, A2A adenosine receptor, A2B adenosine receptor, human neuroendocrine tumours, cell proliferation, chromogranin A. ... Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy. Purinergic Signalling 8 (2 ... Adenosine, released during cellular stress, damage and hypoxia, is a major regulator of angiogenesis. Herein, we describe the ...http://orca.cf.ac.uk/23593/
List of MeSH codes (D13) - Thư viện Khoa học VLOS
MeSH D13.695.667.138.124.070.075 --- adenosine diphosphate glucose * MeSH D13.695.667.138.124.070.125 --- adenosine diphosphate ... n-ethylcarboxamide) * MeSH D13.570.583.138.240 --- s-adenosylhomocysteine * MeSH D13.570.583.138.264 --- s-adenosylmethionine ... MeSH D13.695.827.068.124.070.075 --- adenosine diphosphate glucose * MeSH D13.695.827.068.124.070.125 --- adenosine diphosphate ... MeSH D13.570.583.138 --- adenosine * MeSH D13.570.583.138.025 --- adenosine-5'-( ...https://tusach.thuvienkhoahoc.com/wiki/List_of_MeSH_codes_
Cytotoxicity, Immunologic | The Chopra Library
N-ethylcarboxamide). Adenosine A2 Receptor Agonists. Animals. Cell Line, Tumor ... A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich ... adenosine receptor. This A(2A) adenosine receptor-mediated immunosuppression is a disqualifying obstacle in cancer ... BACKGROUND AND PURPOSE: The increased levels of extracellular adenosine in inflamed tissues down-regulate activated immune ...http://isharonline.org/tags/cytotoxicity-immunologic
Repeated Dosing with Oral Allosteric Modulator of Adenosine A1 Receptor Produces Tolerance in Rats with Neuropathic Pain |...
... of intrathecal injection of the adenosine receptor agonists R-phenylisopropyl-adenosine and N-ethylcarboxamide-adenosine on ... such as allosteric adenosine receptor modulation or inhibition of adenosine kinase 9,10 or adenosine deaminase, 11 have been ... Although adenosine agonists were shown to attenuate pain behaviors in a variety of animal models, adenosine agonists are also ... Keil GJ, DeLander GE: Spinally-mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine ...http://anesthesiology.pubs.asahq.org/article.aspx?articleid=1943048
NAVER Academic > Search...
Adenosine, analogs & derivatives, pharmacology, Adenosine-5'-(N-ethylcarboxamide), Animals, Caffeine, Corpus Striatum, ... Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons.. 1993 S N Schiffmann et al. ... Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression.. 1993 D T Chalmers et al. JOURNAL OF NEUROSCIENCE ...https://academic.naver.com/search.naver?field=3&query=JOURNAL+OF+NEUROSCIENCE+13%EA%B6%8C+3%ED%98%B8
Adenosine-Stimulated Atrial Natriuretic Peptide Release Through A1 Receptor Subtype | Hypertension
A relationship between adenosine and the cardiac hormone ANP is not fully studied despite the existence of adenosine receptors and their effects in the heart. Our study has revealed that adenosine increases an ANP release with negative inotropism via stimulation of A1 receptor subtype and that cellular cAMP level regulates the ANP release.. Adenosine is well known as a physiological regulator of tissue function by increasing the energy supply and decreasing the energy demand. Adenosine also exerts a protective role against ischemic injury. In addition to cardioprotective effects, adenosine inhibits a release of vasopressor hormones. These hormonal effects may be expected to exert beneficial effects on the overloaded heart. We found that adenosine increases the ANP release directly from beating atria with negative inotropism. Our results agree with other reports that ...